Lucence announces the launch of SARS-CoV-2 RNA RT-PCR clinical testing service to support Singapore’s anti-COVID-19 efforts.

Highlights
May 25, 2020

We are launching our SARS-CoV-2 RNA RT-PCR clinical testing service on 26 May 2020 to support Singapore’s anti-COVID-19 efforts.

The Lucence team has worked tirelessly to build this service, which has been approved by the Ministry of Health Singapore, and independently validated by the European QCMD (Quality Control of Molecular Diagnostics). Together we will flatten the curve and work towards restoring the community.

Please visit https://lnkd.in/gs_KpzQ or contact us at for more information.

Need Help?